Advances in Cancer Immunotherapy (ACI) Webinars

ACI programs are certified for CME, CNE, CPE, and MOC credits. ACI's offer in-depth clinical training in immunotherapy treatment for a variety of disease states and topics. ACI webinars are FREE for healthcare professionals, students, patients and patient advocates.

SITC-NCI Computational Immuno-oncology Webinar Series

Advance your training in computational immuno-oncology and stay abreast of the latest technologies - register today for the entire series of nine FREE webinars from SITC.

Targets for Cancer IO: A Deep Dive

The Society for Immunotherapy of Cancer (SITC) is pleased to announce our fourth Targets for Cancer IO: A Deep Dive live webinar series. Key leaders in the field who are experts in their respective fields will provide an overview of the current state of the science and address questions about its future. 

Clinical Practice Guidelines Online Education

The SITC Clinical Practice Guideline (CPG) Webinars connect clinicians with leading experts in the field and provide education about the evidence- and consensus-based recommendations in the CPGs. Educational webinars accompany each CPG and describe recommended uses of immunotherapies for a specific disease state or area and how to manage immune-related adverse events (irAEs), as well as provide practical experience through case studies examples.

SITC Summit on Intralesional Immunotherapy: Moving Beyond Oncolytic Viruses

Sept. 19, 2024 - 11 A.M.–3:15 P.M. EDT

This open-door virtual educational event will present the current state and future directions of the field and feature participation of invited stakeholders involved in intralesional immunotherapy research and development, including clinicians and researchers from academia and industry.

2024 Glyco-Immunology Webinar Series 

July - September 2024

The 2024 Glyco-Immunology Webinar Series consists of three free, two-hour public webinars that feature expert invited speakers and attendee question and answer periods. This series will highlight exciting questions and opportunities in the field of glyco-immunology, an emerging area within the field of immuno-oncology. The primary objective of the SITC SfG Glyco-Immunology Webinar Series is to highlight clinical and translational opportunities and challenges in the field of glyco-immunology.

Increasing Access to IO: A Global Webinar Series

June - November 2024

The Global Access and Impact Committee, in collaboration with the Diversity, Equity, and Inclusion Committee, is pleased to launch SITC’s first educational program crafted specifically for international audiences, titled “Increasing Access to IO: A Global Webinar Series”. The objective of this webinar series is to create a platform for international stakeholders to discuss critical topics and challenges they face when treating patients with immunotherapy, with a key goal of providing education and bringing awareness to the barriers currently impeding equitable access to IO around the globe.

SITC Summit on Immunomodulation of Antibody-drug Conjugates

June 26, 2024 - 11 a.m.–3:30 p.m. EDT

The primary objective of the SITC Summit on Immunomodulation of ADCs is to elucidate the mechanistic aspects of ADC monotherapies and combination therapies. Secondary goals include exploring the effects of ADCs on the immune system, tumor microenvironment and anti-tumor immunity, reviewing clinical considerations for ADC-based therapies, discussing the rationale of using immunoconjugates for targeted cancer therapy.

Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations from the Society for Immunotherapy of Cancer & the International Bladder Cancer Group

March 18, 2024, from 4–5 p.m. CST

On behalf of the Society for Immunotherapy of Cancer (SITC) and the International Bladder Cancer Group (IBCG), we are pleased to announce the publication of the “Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group,” in the Journal of Clinical Oncology. 

Expanding Access to Cellular and Bispecific Therapies

March 14, 2024, from 4–5 p.m. CST

At the SITC ACCC Expanding Access to Cellular and Bispecific Therapies workshop, SITC and ACCC gathered experts tasked with providing recommendations for centers interested in opening cellular therapy and bispecific programs. Through group discussion, the workshop came to consensus on a number of recommendations that address three distinct categories. These recommendations are detailed as actions suggested to be taken prior/while opening a program.

Immune Exclusion Virtual Summit 

 Sept. 18, 2023, from 12–5 p.m. EDT

SITC hosted the Immune Exclusion Virtual Summit on Monday, Sept. 18, 2023, from 12–5 p.m. EDT. The summit was a free, public event that featured invited speakers, expert panel discussions, and attendee question and answer periods. The multi-stakeholder virtual summit featured over 25 panelists representing academic research and industry from around the world. The primary objective of the SITC Immune Exclusion Virtual Summit is to elucidate the molecular mechanisms of immune exclusion in distinct tumor types.

SITC Immunoprevention Virtual Summit

April 3, 2023 from 12–5 p.m. EDT

The Society for Immunotherapy of Cancer (SITC) held the Immunoprevention Virtual Summit on Monday, April 3, from 12–5 p.m. EDT. The summit was a free, public event that featured expert panel discussions, invited speakers, and attendee question and answer periods. The multi-stakeholder virtual summit featured over 25 panelists representing funding agencies, academic researchers, the FDA, and industry.

Tumor Immune Microenvironment: A Holistic Approach

April 21–22, 2022

SITC invites you to attend the workshop, Tumor Immune Microenvironment: A Holistic Approach Workshop, which will focus on the tumor microenvironment and its possible impact on the development of future immunotherapies. Immunotherapeutic approaches are not equally effective across cancer types because not all tumor types are the same. This workshop shines a spotlight on an exciting, emerging area of immunotherapy research.

Bispecific T cell Engagers Virtual Workshop

Sept. 30–Oct. 1, 2021

SITC invites you to attend the workshop, Bispecific T cell Engagers Virtual Workshop. This workshop will focus on T cell engager biology and therapeutic strategies including target selection, therapeutic engineering and design features, cytotoxicity vs cytokine release, impact of the tumor microenvironment, and advances in conditionally-active binding.

Interrogating the Tumor-Specific Surfaceome for Immune Targeting Virtual Workshop

Sept. 29–30, 2021

SITC invites you to attend the virtual workshop, Interrogating the Tumor-Specific Surfaceome for Immune Targeting Workshop. This workshop will focus on the tumor cell surfaceome and the many opportunities that accompany it for the development of future immunotherapies and maximization of existing techniques.